flames handball facebook

View real-time stock prices and stock quotes for a full financial overview. Already a subscriber? Alexion Pharmaceuticals shares outstanding for the quarter ending December 31, 2020 were 0.222B, a 1.25% decline year-over-year. They have voting rights and represent ownership in the corporation by the person that holds the shares. Alexion Pharmaceuticals Inc. represents 220.60 million in outstanding shares, while the company has a total market value of $24.55 billion with the latest information. Alexion started the day with a market cap of around $26.5 billion with approximately 218.8 million shares outstanding and a short interest of about 1.9%. Alexion Pharmaceuticals's Accounts Receivable for the three months ended in Dec. 2020 was $1,409 Mil.Alexion Pharmaceuticals's Revenue for the three months ended in Dec. 2020 was $1,592 Mil.Hence, Alexion Pharmaceuticals's days sales outstanding for the three months ended in Dec. 2020 was 80.79. Stock analysis for Alexion Pharmaceuticals Inc (ALXN:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. The tender offer for all of the outstanding shares of common stock of Portola at a price of $18.00 per share expired as scheduled, one minute following 11:59 p.m., New York City time, on July 1, 2020. In depth view into Alexion Pharmaceuticals Shares Outstanding including historical data from 1996, charts, stats and industry comps. Portola is now a wholly owned subsidiary of Alexion. ALXN vs. BMRN: Which Stock Is the Better Value Option. Alexion Pharmaceuticals, Inc. is a biopharmaceutical company. Alexion Pharmaceuticals shares outstanding history from 2006 to 2020. Portola is now a wholly owned subsidiary of Alexion. ALXN stock price has been found in the range of $112.85 to $115.00. (ii) Any references to the issued and to be issued ordinary share capital of Alexion are based on: • the 218,720,567 Alexion Shares referred to in paragraph (i) above; and Backlinks from other websites are the lifeblood of our site and a primary source of new traffic. An increase in shares outstanding over time reduces EPS growth while a decrease in shares outstanding over time increases EPS growth. The company, currently valued at $34.94 Billion, closed the recent trade at $159.94 per share which meant it gained $2.03 on the day or … Alexion Pharmaceuticals (ALXN) - Get Report shares surged higher Monday after the rare disease specialist agreed to a $39 billion takeover by Britain's AstraZeneca (AZN) - Get Report. The volume of stock shares issued by the company and in the hands of the public. Please try again by refreshing your browser or contact us with details of your problem. GAAP vs. Non-GAAP Earnings. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has a beta value of 1.33 and has seen 2,217,024 shares traded in the recent trading session. Alexion Announces Upcoming Data Presentations at the 73rd Annual Meeting of the American Academy of Neurology, AstraZeneca sold its stake in Moderna for more than $1 billion, as it looks to develop its own pipeline of drugs, AstraZeneca Sold Its Stake in Rival Covid-19 Vaccine Maker Moderna for More Than $1 Billion, INVESTIGATION ALERT: Halper Sadeh LLP Investigates the Following Companies on Behalf of Shareholders - CLGX, CATM, CHNG, ALXN, MDCA, Arcturus Therapeutics Obtains Exclusive License to Alexion's mRNA Manufacturing Technology. ALXN shares opened 30% higher today at $157.35 (+$36.37, +30.06%) over Friday's $120.98 closing price and reached a new 52-week high price this morning of $160.03. Alexion Pharmaceuticals 2020 shares outstanding were 0.222B, a 1.25% decline from 2019. As part of the deal, Alexion will … How Many Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Shares Do Institutions Own? An error occurred. Alexion Pharm Shares Owned by Institutions is currently at 93.36%. The company, currently valued at $27.07 Billion, closed the recent trade at $122.85 per share which meant it gained $6.77 on the day or … A decreasing shares outstanding over time may be the result of company buybacks. The tender offer for all of the outstanding shares of common stock of Portola at a price of $18.00 per share expired as scheduled, one minute following 11:59 p.m., New York City time, on July 1, 2020. The combination values Alexion … Why Is Alexion (ALXN) Down 3.5% Since Last Earnings Report? Changes in shares outstanding have an inverse impact on change in EPS growth. (i) As at 9 December 2020, there were 218,720,567 Alexion shares outstanding. There is no data for the selected date range. Alexion started the day with a market cap of around $26.5 billion with approximately 218.8 million shares outstanding and a short interest of about 1.9%. Vertex Stock Fell After a Setback on a New Drug. In depth view into Alexion Pharmaceuticals Average Basic Shares Outstanding (Quarterly) including historical data from 1996, charts, stats and industry comps. Please check your download folder. Alexion Pharmaceuticals, Inc. Common Stock (ALXN) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. It’s an Opportunity for Investors. If you use our datasets on your site or blog, we ask that you provide attribution via a "dofollow" link back to this page. (ii) Any references to the issued and to be issued ordinary share capital of Alexion are based on: the 218,720,567 Alexion Shares referred to in paragraph (i) above; and The tender offer for all of the outstanding shares of common stock of Portola at a price of $18.00 per share expired as scheduled, one minute following 11:59 p.m., New York City time, on July 1, 2020. Alexion Pharmaceuticals Shares Outstanding (Diluted Average) Calculation Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. The International Securities Identification Number for the Alexion Shares is US0153511094. Alexion is the global leader in complement inhibition and has developed and commercializes the first and only approved complement inhibitor to treat patients with paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG). In addition, the depositary has advised Alexion that, as of the offer expiration time, Notices of Guaranteed Delivery had been delivered with respect to 2,701,052 additional shares, representing approximately 3.4% of the shares outstanding. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has a beta value of 1.28 and has seen 2,539,339 shares traded in the recent trading session. We have provided a few examples below that you can copy and paste to your site: Your data export is now complete. Alexion Pharmaceuticals Shares Outstanding decreased from 224 Mil in 2017 to 223 Mil in 2019, a -0.3% decrease. STOCK ALERT: Halper Sadeh LLP Investigates MGLN, CATM, EGOV, ALXN; Shareholders Are Encouraged to Contact the Firm, SHAREHOLDER ALERT: WeissLaw LLP Reminds BFTL, ALXN, BRPA, and KTYB Shareholders About Its Ongoing Investigations, Crispr Therapeutics Hits 80-Plus Relative Strength Rating Benchmark, INVESTIGATION ALERT: Halper Sadeh LLP Investigates ALXN, CATM, RNET, MDCA, SPWH; Shareholders are Encouraged to Contact the Firm. View the latest Alexion Pharmaceuticals Inc. (ALXN) stock price, ... A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Using Alexion and Portola’s combined shares outstanding of 303 million, this would add about $1.60 to Alexion’s quarterly earnings per share (EPS), which is already currently around $2.50. View and export this data going back to 1996. ... available to common stockholders for the trailing twelve months by the trailing twelve-month diluted weighted average shares outstanding. Alexion Pharmaceuticals 's market cap is calculated by multiplying ALXN 's current stock price of $152.75 by ALXN 's total outstanding shares of 218,845,432 . This metric excludes the company's treasury shares. With about 78.08 million shares outstanding, that offer price implies a market capitalization of $1.41 billion. Alexion Pharmaceuticals, Inc. is a global biopharmaceutical company focused on serving patients and families affected by rare diseases through the innovation, development and commercialization of life-changing therapies. INVESTIGATION ALERT: Halper Sadeh LLP Investigates the Following Companies on Behalf of Shareholders - MDCA, VIE, CLGX, ALXN, TCF, SHAREHOLDER ALERT: WeissLaw LLP Reminds GIX, ALXN, STPK, and BRPA Shareholders About Its Ongoing Investigations, INVESTIGATION ALERT: Halper Sadeh LLP Investigates MDCA, FFG, ALXN, NK, HLIX; Shareholders Are Encouraged to Contact the Firm, SHAREHOLDER ALERT: WeissLaw LLP Reminds NPA, THBR, GIX, and ALXN Shareholders About Its Ongoing Investigations. For advanced charting, view our full-featured. This number entails how much is being traded in the open market. AstraZeneca will pay $60 a share in cash for Boston-based Alexion, as well as 2.1243 of its U.S.-listed shares per each outstanding Alexion share. Portola is now a wholly owned subsidiary of Alexion. In connection with the merger, all shares of Portola common stock outstanding immediately prior to the effective time (other than shares owned by Alexion… The International Securities Identification Number for the Alexion Shares is US0153511094. If you use our chart images on your site or blog, we ask that you provide attribution via a "dofollow" link back to this page. ALXN | Complete Alexion Pharmaceuticals Inc. stock news by MarketWatch. We have provided a few examples below that you can copy and paste to your site: Your image export is now complete. CHESHIRE, Conn.--(BUSINESS WIRE)-- Alexion Pharmaceuticals, Inc. (Nasdaq:ALXN) announced today that it has accepted for exchange all 21,021,124 shares validly tendered into the previously announced exchange offer by a wholly owned subsidiary of Alexion to acquire all of the outstanding shares of Synageva BioPharma Corp. for the agreed consideration of $115.00 in cash and 0.6581 shares … Please check your download folder. SHAREHOLDER ALERT: WeissLaw LLP Reminds BFTL, ALXN, STPK, and BRPA Shareholders About Its Ongoing Investigations. Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by Alexion Pharm that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. In connection with the merger, all shares of Portola common stock outstanding immediately prior to the effective time (other than shares owned by Alexion… The Company is focused on the development and commercialization of therapeutic products. Find out all the key statistics for Alexion Pharmaceuticals, Inc. (ALXN), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. Alexion Pharmaceuticals Shares Outstanding 2006-2020 | ALXN, Alexion Pharmaceuticals shares outstanding for the quarter ending December 31, 2020 were, Alexion Pharmaceuticals 2020 shares outstanding were, Alexion Pharmaceuticals 2019 shares outstanding were, Alexion Pharmaceuticals 2018 shares outstanding were. In connection with the merger, all shares of Portola common stock outstanding immediately prior to the effective time (other than shares owned by Alexion… Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. (i) As at 9 December 2020, there were 218,720,567 Alexion shares outstanding. Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares. Market capitalization (or market value) is the most commonly used method of measuring … Sign in. Companies frequently make stock buybacks and retire those buybacks as treasury stock. Alexion Pharmaceuticals 2019 shares outstanding were 0.225B, a 0.13% increase from 2018. In addition, Alexion has two highly innovative enzyme replacement therapies for patients with life-threatening and ultra-rare metabolic disorders, hypophosphatasia (HPP) and lysosomal acid lipase deficiency (LAL-D).

Bergfex Wetter Kappl, Vfl Potsdam B Jugend, Miu Miu Parfum Müller, Ungarn Land Englisch, Hcf Vs Hbf, Ascii Art Faces, Omron M700 Bedienungsanleitung, Omron M700 Intelli It Media Markt, Traumacare Shoppers Drug Mart,